In patients with renal insufficiency, the elevated plasma nonprotein nitrogen cannot be accounted for solely by the rise in the urea nitrogen (2) . It is known that other nitrogenous materials such as creatinine and uric acid contribute to this elevation. Since free amino acids also contribute to the nonprotein, nonurea nitrogen of plasma, several investigators have determined the amino acid composition of plasma from both normal subjects and patients with uremia. They have shown that in uremia, concentrations of the individual plasma are normal or that such alterations in concentrations as exist are slight and probably insignificant (3) (4) (5) (6) (7) . In addition, the total a-amino nitrogen in plasma of patients with uremia remains approximately normal (3) (4) (5) (6) (7) (8) (9) (10) . However, studies in which deproteinized plasma was hydrolyzed revealed that some anmino acids are variably increased in concentration (34) . These findings suggested the presence of one or more amino acid conjugates in the plasma of patients with uremia.
The investigations described in this paper were undertaken to characterize further the amino acid conjugates in the plasma of patients with uremia. The general plan of the study consisted of measurement of a-amino nitrogen in deproteinized plasma of normal subjects, and of patients with uremia before and after hydrolysis. By means of dialysis through cellophane, rough indications were obtained of the molecular size of conjugates containing nitrogen. By chromatographic separation and serial fraction collections, the sources of conjugate nitrogen were concentrated. At-* Presented in part at the combined Annual Meetings of the American Society for Clinical Investigation and the American Federation for Clinical Research, Atlantic City, N. J., May, 1960 (1) . This Triplicate aliquots of each specimen, before and after hydrolysis, were placed in the ninhydrin reaction vessels, buffered to pH 6.1, and incubated 12 hours at 400 C with urease (10) . The urease had previously been purified by dialysis to remove canavanine and other ninhydrinreacting substances, thus reducing the "blank" determination (13) . After 12 hours of incubation the reaction mixture was found to be free of urea, as determined by the method of Van Slyke and Cullen (14) . Under the conditions described, less than 12 hours' incubation with CONJUGATED AMINO ACIDS IN PLASMA OF PATIENTS WITH UREMIA urease was inadequate. The 12 hours of incubation did not alter the a-amino nitrogen determination of sample plasmas. Recovery of a-amino nitrogen added as glycine and glutamic acid to uremic plasma was 100 ± 2 per cent. Plasma urea nitrogen was performed in duplicate (14) ; uremic plasma specimens were diluted with water (usually 1: 10) so that all titrations were performed in the same range.
Dialysis of amino acid conjuigates. After removal of picrate, plasma filtrates were concentrated 4 X on a rotary evaporator and adjusted to pH 3.4. Using the Craig, King and Stracher dialysis cell (15), 2 ml of the specimen was placed in an acetylated 18/32 Visking cellophane sac which was then transferred through a series of test tubes containing 5 ml of 0.01 M acetic acid, pH 3.4 (15) . Analyses performed on the dialysate, on an aliquot of the initial specimen, and on the material remaining in the sac at the end of the experiment included: colorimetric ninhydrin after alkaline hydrolysis in triplicate (16) , urea (14) , glucose (17) . (20) . These were pumped through at a rate of 50 ml per hour, and approximately 300 3.0-ml fractions were collected. Unhydrolyzed aliquots of these fractions were analyzed for color developed with ninhydrin (21) . Additional aliquots of these same fractions Dialysis of amino acid conjugates. The compounds which gave rise to the increased a-amino nitrogen upon hydrolysis dialyzed rapidly through cellophane. Efforts to increase the selectivity of the experiment by slowing the rate of dialysis were only partially successful, although acetylation of the membrane and dialyzing into 0.01 M acetic acid did slow the rate, as noted by Craig and co-workers (15) . After one experiment, manometric CO2-ninhydrin determinations on the dialysate were made, but dialysis of the unknown proceeded so rapidly that the concentration of a-amino nitrogen (after hydrolysis) in the dialysate fell off quickly. That is, only the earliest tubes of dialysate contained any reliably detectable a-amino nitrogen. The calorimetric ninhydrin method was applied and proved to be more sensitive than the manometric method. In these experiments alkaline hydrolysis was selected because any ammonia formed would be driven off. In specimens from normal subjects, there was essentially no conjugated amino nitrogen, as shown by a lack of change in ninhydrin color after hydrolysis. In specimens from patients with uremia, conjugate N dialyzed at a rate slower than that of urea, but faster than that of glucose (Figure 1 ). When the simple tripeptide glycylglycylglycine (mol wt 189) was added to deproteinized normal plasma, it dialyzed at the same rate as glucose (mol wt 185). Similar results were obtained on specimens deproteinized by ultrafiltration.
Chromatographic separation of amino acid conjugates on ion-exchange resins. Figure 2 illustrates the amino acid pattern obtained by ion-exchange chromatography on Amberlite 1R 120 of picric acid-deproteinized normal plasma. It can be seen that no additional peaks resulted upon hydrolysis; i.e., no conjugated amino N was detected in the range examined. At the end of the scheme shown in Figure 2 , the pH was progressively raised, resulting in separation and elution of the acidic, neutral, and basic amino acids in series (20) (vide infra). Figure 3 illustrates the typical result obtained in an identical experiment with a similarly prepared plasma from a patient with uremia. After hydrolysis of aliquots of the fractions, three distinct peaks, labeled A, B, and C were found where there was little or no color prior to hydrolysis. Chromatography of the contents of peak C on Dowex-1 resulted in a single peak detectable only by performing the ninhydrin color after hydrolysis. Hydrolysis of pooled fractions was performed in a sealed glass tube with 6 N HCl, after which the HCl was evaporated. When the desalted (28) specimen was examined by two-dimensional paper chromatography, a single spot of glutamic acid was identified. An aliquot of the hydrolysate, which was subjected to quantitative analysis by an ion-exchange chromatography system employing an automatic recorder (27) , revealed only glutamic acid and ammonia. This substance, therefore, had the properties of phenylacetylglutamine (PAG) as determined by Stein, Paladini, Hirs and Moore (24) . Synthetic 
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and neutral amino acids were identified, as shown in Figure 4 . The prominent peak at 80 effluent ml displayed an optical density at 440 miu which is higher than that seen with urea which is eluted in this area. An aliquot of the hydrolysate (prior to this chromatography) gave a negative urease reaction. The contents of this peak were not identified, but a dense brownish mass, probably representing a fraction of the soluble humin, was eluted from the column at a time corresponding to this peak. No basic amino acids were present. Chromatography of the unhydrolyzed specimen yielded a small ninhydrin-positive peak emerging before the position of taurine. Peak A yielded the same amino acids after acid hydrolysis as did peak B.
Other amino acid conjugates. The large increase in ninhydrin color after hydrolysis of the tubes containing urea suggested that this peak might contain other amino acid conjugates. However, when the tubes were pooled, the volume reduced by evaporation, and the contents hydro- lyzed, no amino acids were found upon ionexchange chromatography. The concentration of taurine was not specifically determined in the plasmas studied but appeared to be variable. No additional amino acids were found underlying the taurine peak. In two experiments, the automatic recording apparatus employing a 150 x 0.9 cm resin column for acidic and neutral ninhydrinreacting components and a 50 x 0.9 cm column for basic components (30) was modified to allow splitting of the effluent stream at the bottom of the column (31) . One-tenth of the effluent was directed through the reaction bath and photometers of the apparatus in the normal fashion. The remainder was directed to a fraction collector, and over 600 2.0-ml fractions were collected. 
FIG. 4. RECORDING FROM AUTOMATIC AMINO ACID ION-EXCHANGE CHROMATOGRAM OF CONTENTS OF PEAK B, FIG-URE 3, AFTER ACID HYDROLYSIS.
The material in the early part of the record represents decomposition products from the plasma glucose and citrate buffer from the preparatory separation (see text).
the previously described 1 hour acid hydrolysis was used. In these experiments no prominent conjugate other than PAG and the peaks A and B were noted. A small post-hydrolysis peak was found between the peaks of glutamine-asparagine and proline. This peak contained only glycine after hydrolysis. The contents of tubes corresponding to the peaks of plasma amino acids were pooled, hydrolyzed, de-salted, and examined by paper chromatography. In no instance was there found any additional amino acid which would indicate a conjugate obscured on the chromatograph recording by the expected amino acid.
Because of our failure to locate hippuric acid, a conjugate known to be present in normal urine (24) , radioactive hippuric acid was synthesized from C'4-glycine and benzoyl chloride (32) . On the 1.8 x 165 cm column. C14-hippuric acid was not eluted with the pH 2.2 buffer but was eluted with pH 3.25 buffer in a complex peak which also contained serine, glutamine, and asparagine. On the 0.9 cm column of the automatic apparatus, the C14-hippuric acid was eluted in a position corresponding to that of the unknown glycine-containing peak in plasma from patients with uremia.
DISCUSSION
The finding of increased a-amino nitrogen after hydrolysis of deproteinized plasma from patients with uremia confirms the findings of previous investigators (2) (3) (4) (5) (6) (7) . The dialysis experiments indicated that the substances giving rise to increased ninhydrin color after alkaline hydrolysis were of low molecular weight.
Our * ; * + + . -e t . -I . , + , 0 j -. -0 , j . , reported a normal daily excretion of 250 to 500 mg (24) . However, the amiiount of PAG apparently present in the plasmas from patients with uremia was surprisingly large. The fact that none was detected in the plasma specimens from normal subjects suggests that PAG is secreted by the renal tubules, as are similar acyl amino acids (33) . Furthermore, there is evidence that excreted PAG is synthesized in part in the renal tubular cells (34) .
It is interesting to compare the apparent retention of PAG with that of hippuric acid, a similar amino acid conjugate. Stein and colleagues reported a normal daily excretion of hippuric acid of 1.0 to 2.5 g (24) . In contrast to PAG, only relatively small amounts of hippuric acid were apparently present in our plasmas from patients with uremia. This might have been partially attributable to the method employed, since PAG would liberate NH3 on acid hydrolysis and thereby increase the ninhydrin color value, whereas hippuric acid would not. Also, hippuric acid was eluted at a more complicated position in the ionexchange chromatogram. Alternative explanations for the relatively low plasma hippuric acid should be considered. First, there might be a decrease in the formation of hippurate. The origin of benzoic acid to form urinary hippuric acid is not known and may be, at least in part, dietary. These patients had poor dietary intake. Second, the production of PAG might be increased in some way, perhaps as the result of accelerated endogenous protein catabolism. The answer to the problem must be complicated and may include consideration of the differential effect of the uremic state upon many enzyme systems.
The presence of large amounts of IPAG in the plasma of patients with uremia raised the question of whether the precursors might be increased in concentration. One of these, phenylacetic acid (PAA), has been shown to have untoward effects in man (35) . However, plasma concentrations of glutamine in patients with uremia are essentially normal (3) (4) (5) (6) and should be adequate to combine with PAA. We were unable to demonstrate the presence of PAA in plasma from patients with uremia. Whole plasma from such patients in amounts up to 250 ml (pooled) was acidified and extracted 5 x with dichloromethane.
Evaporation yielded an oily, brownish material which was more plentiful and darker than that similarly obtained from plasma from normal subjects. This material was subjected to paper chromatography according to the method of Ladd and Nossal (36) . No PAA was found in the extracts, although standard organic acids chromatographed well. This does not rule out the possibility that PAA may be present in the plasma of patients with uremia; current methods for detection of PAA lack sensitivity and specificity.
The question of the effects of PAG in such large amounts in the plasma naturally arises. We have not studied the toxicity of PAG, nor have others reported on this subject. A large number of nonprotein nitrogenous substances is known to be present in increased amounts in the plasma in uremia. These include urea, creatinine, phenols, and so forth. Although each of these substances may have untoward effects under certain circumstances, it is generally accepted that the uremic syndrome is due to a multiplicity of factors rather than a single agent (37, 38) .
Moldave and Meister noted that the enzyme of human liver and kidney which is responsible for the conjugation of glutamine with phenylacetate to form PAG also catalyzes the reaction of phenylacetate with glycine to form a slight amount of phenylacetylglycine in vitro (34) . C14-phenylacetylglycine was synthesized by reacting C14-glycine with phenylacetyl chloride (29) . This substance was eluted at 612 effluent ml from the 1.8 x 165 cm column with the pH 2.2 buffer. Nothing was found in this area in our studies of patients with uremia. Therefore, phenylacetylglycine was not present in the plasma of our patients with uremia.
The material in the peaks labeled A and B has not been completely identified. Although some amino acids were identified after hydrolysis, the usual tests for proteins and peptides were negative. The manner of deproteinization and the dialysis experiments also tend to militate against the presence of peptides. This confirms the observations of Christensen and co-workers, who were unable to find an increase in nondialyzable a-amino N in deproteinized uremic plasma (39 (30) . Since one organic acid, phenylacetic acid, is a constituent of one conjugate (peak C) it is conceivable that other conjugates (peaks A and B) represent conglomerates of amino acids with other organic substances.
The two types of study, 1) a-amino N before and after hydrolysis, and 2) chromatographic separation of amino acid conjugates on ion-exchange resins, were not performed on the same specimens. It is apparent that even 20 mg per 100 ml of PAG would yield only about 1 mg per 100 ml of a-amino N. It is difficult to estimate the amount of a-amino N contributed by the conjugates which were incompletely identified. However, it may be anticipated that other analytical procedures will reveal additional sources for the a-amino N liberated by acid hydrolysis.
SUMMARY AND CONCLUSIONS 1. We have confirmed the observation that the a-amino nitrogen in deproteinized plasma from patients with uremia is approximately normal. Acid hydrolysis of deproteinized plasma of uremic patients resulted in an increase in a-amino nitrogen of 1.5 to 7.1 mg per 100 ml, with a mean increase of 3.0 (65 per cent), compared with a mean of 0.6 mg per 100 ml (11 per cent) in normal plasmas.
2. The substances apparently giving rise to the increased a-amino nitrogen dialyzed through cellophane at a rate slower than that of urea, but faster than that of glucose.
3. Amino acid conjugates were separated on ion-exchange resins. Phenylacetylglutamine was found in amounts up to 20 mg per 100 ml in plasma of patients with chronic uremia. Thus, phenylacetylglutamine accounts for a portion of the rise in a-amino nitrogen after hydrolysis of uremic plasmas. No correlation of the concentrations of phenylacetylglutamine with plasma urea nitrogen levels was apparent.
4. Evidence for the presence of other conjugates is offered. The amino acids present in these conjugates were identified. The structure of the organic compounds containing these amino acids has not been determined and requires further study.
